| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159698 Drug product for intestinal disease |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | US20060159632 Drug formulation for mouth or pharynx comprising local anesthetic |
| 07/20/2006 | US20060159626 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680429A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 07/19/2006 | EP1680421A2 Use of tricyclic compounds as glycine transport inhibitors |
| 07/19/2006 | EP1680111A2 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 07/19/2006 | EP1679967A2 Methods of using and compositions comprising selective cytokine inhibitory drus for treatment, modification and management of pain |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1121109B8 Biphasic tramadol preparation |
| 07/19/2006 | EP1075492B1 Melanocortin 1 receptor selective compounds |
| 07/19/2006 | CN1805956A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 07/19/2006 | CN1805739A Anti-inflammatory analgesic adhesive patch |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803152A Pest-clearing toxicide |
| 07/19/2006 | CN1803129A Sodium diclofenac mucilage |
| 07/19/2006 | CN1803128A Oral disintegrating tablet containing tramadol hydrochloride and acetaminopher, and its preparation method |
| 07/19/2006 | CN1264859C Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264817C Certain cyclic thio substituted acylaminoacid amide derivatives |
| 07/19/2006 | CN1264527C Novel olive kernel leaf extracts and preparation process and medical use thereof |
| 07/19/2006 | CN1264515C Externally applied Pioxican preparation and its preparation process |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264505C Freeze dry powder injection of ketoprofen |
| 07/19/2006 | CN1264494C Method for preparing musk freeze-dried powder injection |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078419 Cytokine inhibitors |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078177 Identifying modulators of oncogene receptor binding activity for treating pain, neuropathic and inflammatory, learning and memory, anxiety and cardiovascular disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/18/2006 | US7078053 Ibuprofen composition |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | US7078040 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them |
| 07/18/2006 | CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072792A2 Compounds which bind to the active site of protein kinase enzymes |
| 07/13/2006 | WO2006072783A1 Sulfasalazine analogues as nf-kb inhibitors |
| 07/13/2006 | WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | WO2006072588A1 Substituted 2-amino-quinazolin-4-cn compounds for use in the treatment of cns disorders, pain, stroke, addiction and epilepsy, their preaparation and use as intermediates |
| 07/13/2006 | WO2006057902A3 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/13/2006 | WO2006057901A3 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154954 Combinations and use of selected pharmaceutically active compounds |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154942 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060154854 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 07/13/2006 | US20060154319 Inhibition of bradykinin release |
| 07/13/2006 | US20060153908 Spherical pellet formulations |
| 07/13/2006 | US20060153850 Antibodies to M-CSF |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | CA2592455A1 Substituted 2-amino-quinazolin-4-cn compounds for use in the treatment of cns disorders, pain, stroke, addiction and epilepsy, their preaparation and use as intermediates |
| 07/13/2006 | CA2590110A1 Kinase modulators and method of use |
| 07/12/2006 | EP1679316A1 Stable vitamin b6 derivative |
| 07/12/2006 | EP1679301A1 Esters of nonsteroidal anti-inflammatory drugs and methods of their preparation |
| 07/12/2006 | EP1679296A1 Ether derivative |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |